Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,390 | 82 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $373.66 | 22 | $0 (2024) |
| Covidien LP | $95.28 | 4 | $0 (2019) |
| TELA Bio, Inc. | $79.07 | 5 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $71.06 | 3 | $0 (2023) |
| Pacira Pharmaceuticals Incorporated | $64.55 | 3 | $0 (2023) |
| AbbVie Inc. | $52.31 | 3 | $0 (2023) |
| TETRAPHASE PHARMACEUTICALS, INC. | $52.15 | 3 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $49.07 | 4 | $0 (2019) |
| Osiris Therapeutics Inc. | $46.30 | 4 | $0 (2019) |
| ConvaTec Inc. | $45.26 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104.46 | 5 | Merck Sharp & Dohme LLC ($58.90) |
| 2023 | $219.51 | 12 | Merck Sharp & Dohme LLC ($79.72) |
| 2022 | $122.82 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($48.06) |
| 2021 | $120.85 | 7 | TELA Bio, Inc. ($62.17) |
| 2020 | $89.47 | 5 | Sanara MedTech Inc. ($23.20) |
| 2019 | $329.29 | 21 | Merck Sharp & Dohme Corporation ($125.65) |
| 2018 | $303.45 | 19 | Covidien LP ($82.56) |
| 2017 | $99.86 | 7 | Merck Sharp & Dohme Corporation ($47.31) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Baxter Healthcare | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Surgical Care | ||||||
| 08/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: ONCOLOGY | ||||||
| 03/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: ONCOLOGY | ||||||
| 02/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Oncology | ||||||
| 09/19/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Pain Management | ||||||
| 06/13/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: SURGERY | ||||||
| 06/13/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: SURGERY | ||||||
| 05/25/2023 | AbbVie Inc. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/18/2023 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/21/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: ONCOLOGY | ||||||
| 02/14/2023 | Edwards Lifesciences Corporation | HemoSphere (Device) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Hemodynamic Monitoring | ||||||
| 01/10/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: ONCOLOGY | ||||||
| 12/22/2022 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/08/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/04/2022 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Pain Management | ||||||
| 09/06/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/30/2022 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Oncology | ||||||
| 01/04/2022 | Innocoll Pharmaceuticals Limited | XARACOLL (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Prescription Drug | ||||||
| 10/26/2021 | Checkpoint Surgical, Inc | Checkpoint Stimulators (Device) | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Surgery | ||||||
| 08/10/2021 | TELA Bio, Inc. | OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Surgical Mesh | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 458 | 541 | $153,121 | $35,285 |
| 2022 | 12 | 496 | 595 | $168,525 | $38,706 |
| 2021 | 10 | 399 | 493 | $115,422 | $30,790 |
| 2020 | 12 | 403 | 475 | $119,927 | $30,997 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 94 | 94 | $19,274 | $6,691 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 114 | $15,611 | $6,667 | 42.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 22 | 22 | $17,104 | $3,787 | 22.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 19 | 19 | $14,771 | $3,252 | 22.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $21,329 | $3,239 | 15.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 33 | $8,725 | $3,135 | 35.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 29 | 30 | $20,253 | $2,393 | 11.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 62 | $4,687 | $2,368 | 50.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 37 | $3,038 | $1,491 | 49.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $9,329 | $1,477 | 15.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 92 | 95 | $19,000 | $785.26 | 4.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 176 | $24,101 | $10,130 | 42.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 97 | 97 | $19,889 | $6,209 | 31.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 26 | 26 | $20,213 | $4,680 | 23.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 23 | 23 | $17,881 | $3,994 | 22.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 30 | $7,932 | $2,819 | 35.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 27 | 28 | $18,903 | $2,679 | 14.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $12,983 | $2,091 | 16.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $11,662 | $1,994 | 17.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 43 | $3,247 | $1,264 | 38.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $7,599 | $1,195 | 15.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 108 | 114 | $22,800 | $1,046 | 4.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 16 | $1,314 | $605.30 | 46.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 121 | 183 | $25,060 | $11,249 | 44.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 76 | 76 | $15,583 | $5,868 | 37.7% |
About Dr. David Robertson, MD
Dr. David Robertson, MD is a Surgery healthcare provider based in Lancaster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811983067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Robertson, MD has received a total of $1,390 in payments from pharmaceutical and medical device companies, with $104.46 received in 2024. These payments were reported across 82 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($1,390).
As a Medicare-enrolled provider, Robertson has provided services to 1,756 Medicare beneficiaries, totaling 2,104 services with total Medicare billing of $135,778. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Location Lancaster, OH
- Active Since 09/23/2005
- Last Updated 01/17/2024
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1811983067
Products in Payments
- KEYTRUDA (Biological) $357.55
- GATTEX (Drug) $96.54
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) $62.17
- Xerava (Drug) $52.15
- Exparel (Drug) $47.78
- Spacemaker (Device) $44.20
- Situate (Device) $38.36
- PREPOPIK (Drug) $37.83
- CREON (Drug) $35.74
- GRAFIX/GRAFIXPL/STRAVIX (Biological) $34.75
- VOQUEZNA (Drug) $25.64
- ReliaTack (Device) $25.28
- XARACOLL (Drug) $24.05
- CellerateRx (Device) $23.20
- XERAVA (Drug) $20.05
- TISSEEL (Biological) $19.92
- HemoSphere (Device) $19.57
- MOTOFEN (Drug) $18.93
- Phasix (Device) $18.68
- OPTIFIX (Device) $18.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Lancaster
James Rosser, Md, MD
Surgery — Payments: $150,618
Dr. Meghan Dermody, M.d, M.D
Surgery — Payments: $96,684
Glenn Kline, Do, DO
Surgery — Payments: $60,249
Dr. Gennady Landa, Dds, Md, DDS, MD
Surgery — Payments: $25,585
Steven Woratyla, Md, MD
Surgery — Payments: $24,305
Jeffrey Yenchar, Md, MD
Surgery — Payments: $24,114